Aspirin

At 1 year, aspirin plus ticagrelor after CABG was associated with similar saphenous vein graft occlusion, graft failure and bleeding compared with aspirin alone, according to results from the POPular CABG trial.

According to a presentation at the virtual Heart in Diabetes Conference, physicians should discuss CVD risk reduction by the time a woman hits menopause.

Results from the POPULAR TAVI trial demonstrated that omitting clopidogrel after transcatheter aortic valve replacement may reduce bleeding, and aspirin alone may be sufficient to prevent thromboembolic events, researchers reported.

The current literature does not support the use of aspirin for primary prevention in patients with diabetes, and physicians must balance the benefits of prevention with the increased risk for major bleeding, according to a speaker.

A new study showed that aspirin use may accelerate the progression of cancer among older adults. It was the top story in hematology/oncology last week.

Aspirin may accelerate the progression of cancer among older people, according to results of a randomized study published in Journal of the National Cancer Institute.

Effectiveness of ticagrelor (Brilinta, AstraZeneca) plus aspirin compared with aspirin alone in acute ischemic stroke or transient ischemic attack.

Ticagrelor plus aspirin lowered the risk for stroke or death within 30 days compared with placebo in patients with acute ischemic stroke or transient ischemic attack who did not undergo IV or endovascular thrombolysis, researchers found.

Dropping aspirin and continuing with P2Y12 inhibitor monotherapy 1 to 3 months after PCI was safe, according to a new meta-analysis.

Data from Digestive Disease Week showed that aspirin nearly doubled the risk for serious upper gastrointestinal bleeds in older adults. It was the top story in gastroenterology last week.